Table 3. Medications before PE diagnosis.
Total (n = 333) | PE (n = 109) | Non-PE (n = 224) | p | |
---|---|---|---|---|
Aspirin | 45 (14%) | 13 (12%) | 32 (15%) | 0.55 |
Clopidogrel | 11 (3%) | 2 (2%) | 9 (4%) | 0.51 |
Warfarin | 9 (3%) | 4 (4%) | 5 (2%) | 0.48 |
DOAC | 17 (5%) | 11 (10%) | 6 (3%) | 0.004 |
LMWH (prophylactic dose) | 223 (67%) | 66 (61%) | 157 (70%) | 0.08 |
Hydroxychloroquine | 281 (84%) | 88 (81%) | 193 (86%) | 0.2 |
Tocilizumab | 16 (5%) | 5 (5%) | 11 (5%) | 0.9 |
Data are n (%).
PE: pulmonary embolism; DOAC: direct-acting oral anticoagulants; LMWH: low molecular weight heparin.